Key result
Substernal EV-ICD undergoes three-year evaluation in chronic follow-up pilot study.
Key points are not available for this paper at this time.
Three-year pilot data support substernal EV-ICD feasibility; larger randomized trials needed before adoption.
[Figure: see text]
No takes yet. Share an insight, caveat, or question.
Crozier et al. (2023) studied this question. A substernal extravascular implantable cardioverter-defibrillator was evaluated over a three-year chronic follow-up period in a pilot study.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: